Journals / Infectious diseases and clinical microbiology (Online) / 2020 / Cilt: 2 - Sayı: 3

Contaminated Generic Non-approvedRemdesivir Vials: New Risk in Treatmentof COVID-19

Pages
181–183
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

AYGÜN, G., ÜRKMEZ, S., METE, B., KAYHAN, O., KURT, A. F., HOUSSEIN, F. M. (2022). Contaminated Generic Non-approvedRemdesivir Vials: New Risk in Treatmentof COVID-19. Infectious diseases and clinical microbiology (Online), Cilt: 2 - Sayı: 3, 181–183. https://ajindex.com/articles/539124

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. 1 Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020
  2. 2 U. S Food and Drug Anministration. Highlights of prescribing information- VEKLURY® (remdesivir) injection, for intravenous use Initial U.S. Approval: 2020. (cited 2020 December 4) Available from: URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf 3 Gilead Siciences. Press Release Nov 17 2020. (cited 2020 December 4) Available from: URL: https://www.klimik.org.tr/ wp-content/uploads/2020/11/Remdesivir-Basin-Duyurusu.pdf. 4 Vonberg RP, Gastmeier P. Hospital-acquired infections related to contaminated substances. J Hosp Infect 2007
  3. 5 Kauffman CA, Malani AN. Fungal infections associated with contaminated steroid injections. Microbiol Spectr 2016
  4. 6 (cited 2020 December 4) https://wayback.archive-it. org/7993/20170112164908/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm323946.htm